Stay updated with breaking news from Microba Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ColoAlert® Revenue Increases 152% Year Over Year BERKELEY, Calif. and MAINZ, Germany, May 16, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics
ColoAlert® Revenue Increases 152% Year Over Year BERKELEY, Calif. and MAINZ, Germany, May 16, 2023 -- Mainz Biomed N.V. , a molecular genetics diagnostic company specializing in the early... | May 16, 2023
Combination of DNA biomarkers with microbiome biomarkers has potential to enhance technical profile of novel pancreatic cancer screening test Joint research project to discover disease specific... | May 10, 2023
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous Mainz Biomed Partners with Microba Life Sciences for the Development of PancAl...
The diagnostic’s company profit was down 54 per cent, but well above pre-pandemic levels, pushing shares to a three-month-high.